Delcath (DCTH) Moves Higher as FDA Grants Chemosaturation System NDA Standard Review
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Stocks Crossing 50-Day SMA 10/15: (RF) (SNDK) (CSCO) Above; (EBAY) (DCTH) (HRS) Below
October 15, 2012 2:35 PM EDTCrossing and above: Regions Financial Corp. (NYSE: RF) - up 1.2 percent. Moving higher with financials following strong Q3 reports from such names as Citigroup (NYSE: C) and JPMorgan (NYSE: JPM). Regions will report Q3 earnings on October 23rd.
SanDisk (Nasdaq:... More
Delcath (DCTH) Chemosaturation System NDA Accepted by FDA
October 15, 2012 6:43 AM EDTDelcath Systems, Inc. (Nasdaq: DCTH) announced that the U.S. Food and Drug Administration (FDA) has accepted the Company`s New Drug Application (NDA) for its proprietary chemosaturation system with melphalan hydrochloride for injection. The FDA has designated the NDA for standard review.... More
